Press release
Hormone Refractory Prostate Cancer Market to Reflect Impressive Growth Rate During 2016 – 2024 : Persistence Market Research
The driving factors for Hormone Refractory Prostate cancer market are promising pipeline drugs, evolving patterns of treatment, augmented with patient awareness. Larger untapped pool of patients from Asia Pacific region would opt for the treatment of Hormone Refractory Prostate Cancer which will boost the sales revenue in the market. On the other hand premium prices drugs for Hormone Refractory Prostate Cancer, indeterminate reimbursement policies and limited period of survival would hinder the growth of the market over the forecast period. Physicians being reluctant towards promoting and adopting premium would acts as a key challenge in the growth of market players. Whereas untapped patient population with non-metastatic Hormone Refractory Prostate Cancer from emerging countries would open new avenues for the new and existing players. This undiagnosed patient population and mounting prevalence would provide growth opportunities in future.
The global Hormone Refractory Prostate Cancer market is segmented on the basis of type of therapy and end user type
Based on treatment type, global Hormone Refractory Prostate Cancer market is classified as chemotherapy, radiation therapy, surgery, immunotherapy, and hormonal therapy. Surgery is expected to lead the global market for prostate cancer over the forecast period as it is the choice of therapy by physicians. Radiation therapy is used to prevent the recurrence of cancer and is expected to contribute second largest share in the global Hormone Refractory Prostate Cancer market. Chemotherapy is used as an adjunct to other therapies and thus hold little share in global Hormone Refractory Prostate Cancer market.
Based on end user, global Hormone Refractory Prostate Cancer market has been segmented into hospitals, ambulatory surgical centers and specialty clinics. Hospital end user type segment is expected to contribute the highest share in the global market for global Hormone refractory prostate cancer market.
A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/12748
Based on the regional presence, global Hormone Refractory Prostate Cancer market is segmented into five key regions viz. North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. North America will continue to dominate the global Hormone Refractory Prostate Cancer market for due to high prevalence which are diagnosed with advanced technology. It is one of the most common type of malignancy which is observed amongst men in United States and is the second largest cause of Cancer deaths in United States. Europe is expected to hold second largest market share in global Hormone Refractory Prostate Cancer market. Followed by Europe the other regions like Asia Pacific, MEA and Latin America which has a large pool of undiagnosed Hormone Refractory Prostate Cancer would continue to grow with increasing awareness and advanced screening technology.
Some of the key players competing in hormone refractory prostate cancer market include AbbVie Inc., Acceleron Pharma, Inc., AB Science SA, AstraZeneca Plc., Astellas Pharma Inc., Bayer AG, Boston Biomedical, Inc., Bristol-Myers Squibb Company and others.
Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/12748
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
To view complete report @ http://www.persistencemarketresearch.com/market-research/hormone-refractory-prostate-cancer-market.asp
About Us
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web:www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hormone Refractory Prostate Cancer Market to Reflect Impressive Growth Rate During 2016 – 2024 : Persistence Market Research here
News-ID: 586887 • Views: …
More Releases from Persistence Market Research
Dog Collars, Leashes & Harnesses Market Set to Reach US$ 9.51 Bn by 2030
Introduction
The global dog collars, leashes & harnesses market has experienced notable growth in recent years, driven by the rising adoption of companion animals, increasing pet humanization, and growing awareness of pet safety and comfort. Dogs are increasingly regarded as family members, leading pet owners to invest in high-quality, durable, and aesthetically appealing accessories that enhance both functionality and style. Collars, leashes, and harnesses play a critical role in pet control,…
Music Tourism Market Analysis Highlights 5.5% CAGR Through 2032
The global music tourism market is set to witness consistent growth over the next decade, supported by the rising popularity of live music experiences and experiential travel. According to recent industry analysis, the global music tourism market size is likely to be valued at US$9.6 billion in 2025 and is projected to reach US$14.0 billion by 2032, expanding at a compound annual growth rate (CAGR) of 5.5% during the forecast…
Electronic Dance Music Market Analysis Highlights Robust Growth Through 2031
➤ Introduction
The global Electronic Dance Music (EDM) market has emerged as one of the most dynamic and influential segments within the broader music and entertainment industry. Characterized by high-energy beats, immersive live performances, and strong digital integration, EDM has evolved from an underground cultural movement into a mainstream global phenomenon. The genre's rapid adoption across music festivals, nightclubs, streaming platforms, and social media channels has significantly reshaped consumer listening habits…
Global Memory Market Set for Strong Growth Driven by AI and Data Centers
The global memory market is entering one of its most transformative growth cycles in decades. As digital ecosystems scale rapidly across artificial intelligence (AI), cloud computing, data centers, automotive electronics, and edge devices, memory technologies are becoming the backbone of modern computing infrastructure. From high-performance servers to connected vehicles and IoT endpoints, memory capacity, speed, and efficiency now directly influence system performance and competitiveness.
The global memory market size is likely…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
